1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Medical Imaging Reagents Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Medical Imaging Reagents Market, by Modality
8.1.1 X-ray
8.1.1.1. Market Revenue and Forecast
8.1.2. CT Scan
8.1.2.1. Market Revenue and Forecast
8.1.3. Ultrasound
8.1.3.1. Market Revenue and Forecast
8.1.4. MRI Scan
8.1.4.1. Market Revenue and Forecast
9.1. Medical Imaging Reagents Market, by Class
9.1.1. Contrast Reagent
9.1.1.1. Market Revenue and Forecast
9.1.2. Optical Reagent
9.1.2.1. Market Revenue and Forecast
9.1.3. Nuclear Reagent
9.1.3.1. Market Revenue and Forecast
10.1. Medical Imaging Reagents Market, by Application
10.1.1. Neurological Disorder
10.1.1.1. Market Revenue and Forecast
10.1.2. Cardiovascular Disorder
10.1.2.1. Market Revenue and Forecast
10.1.3. Cancer
10.1.3.1. Market Revenue and Forecast
10.1.4. Gastrointestinal Disorder
10.1.4.1. Market Revenue and Forecast
10.1.5. Musculoskeletal Disorder
10.1.5.1. Market Revenue and Forecast
10.1.6. Nephrological Disorder
10.1.6.1. Market Revenue and Forecast
10.1.7. Others
10.1.7.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Modality
11.1.2. Market Revenue and Forecast, by Class
11.1.3. Market Revenue and Forecast, by Application
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Modality
11.1.4.2. Market Revenue and Forecast, by Class
11.1.4.3. Market Revenue and Forecast, by Application
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Modality
11.1.5.2. Market Revenue and Forecast, by Class
11.1.5.3. Market Revenue and Forecast, by Application
11.2. Europe
11.2.1. Market Revenue and Forecast, by Modality
11.2.2. Market Revenue and Forecast, by Class
11.2.3. Market Revenue and Forecast, by Application
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Modality
11.2.4.2. Market Revenue and Forecast, by Class
11.2.4.3. Market Revenue and Forecast, by Application
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Modality
11.2.5.2. Market Revenue and Forecast, by Class
11.2.5.3. Market Revenue and Forecast, by Application
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Modality
11.2.6.2. Market Revenue and Forecast, by Class
11.2.6.3. Market Revenue and Forecast, by Application
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Modality
11.2.7.2. Market Revenue and Forecast, by Class
11.2.7.3. Market Revenue and Forecast, by Application
11.3. APAC
11.3.1. Market Revenue and Forecast, by Modality
11.3.2. Market Revenue and Forecast, by Class
11.3.3. Market Revenue and Forecast, by Application
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Modality
11.3.4.2. Market Revenue and Forecast, by Class
11.3.4.3. Market Revenue and Forecast, by Application
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Modality
11.3.5.2. Market Revenue and Forecast, by Class
11.3.5.3. Market Revenue and Forecast, by Application
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Modality
11.3.6.2. Market Revenue and Forecast, by Class
11.3.6.3. Market Revenue and Forecast, by Application
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Modality
11.3.7.2. Market Revenue and Forecast, by Class
11.3.7.3. Market Revenue and Forecast, by Application
11.4. MEA
11.4.1. Market Revenue and Forecast, by Modality
11.4.2. Market Revenue and Forecast, by Class
11.4.3. Market Revenue and Forecast, by Application
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Modality
11.4.4.2. Market Revenue and Forecast, by Class
11.4.4.3. Market Revenue and Forecast, by Application
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Modality
11.4.5.2. Market Revenue and Forecast, by Class
11.4.5.3. Market Revenue and Forecast, by Application
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Modality
11.4.6.2. Market Revenue and Forecast, by Class
11.4.6.3. Market Revenue and Forecast, by Application
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Modality
11.4.7.2. Market Revenue and Forecast, by Class
11.4.7.3. Market Revenue and Forecast, by Application
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Modality
11.5.2. Market Revenue and Forecast, by Class
11.5.3. Market Revenue and Forecast, by Application
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Modality
11.5.4.2. Market Revenue and Forecast, by Class
11.5.4.3. Market Revenue and Forecast, by Application
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Modality
11.5.5.2. Market Revenue and Forecast, by Class
11.5.5.3. Market Revenue and Forecast, by Application
12.1. Abbott Bracco Spa
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Lantheus Holdings, Inc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. General Electric Company
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Siemens AG
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bayer AG
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. CMC Contrast AB
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Thermo Fisher Scientific Inc
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Merck & Co., Inc
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Shimadzu Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Koninklijke Philips N.V.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
